| Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. L Ruggeri, A Mancusi, M Capanni, E Urbani, A Carotti, T Aloisi, M Stern, ... Blood, The Journal of the American Society of Hematology 110 (1), 433-440, 2007 | 784 | 2007 |
| Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms P Lundberg, A Karow, R Nienhold, R Looser, H Hao-Shen, I Nissen, ... Blood, The Journal of the American Society of Hematology 123 (14), 2220-2228, 2014 | 746 | 2014 |
| Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis A Gratwohl, M Stern, R Brand, J Apperley, H Baldomero, T de Witte, ... Cancer 115 (20), 4715-4726, 2009 | 427 | 2009 |
| Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study K Fleischhauer, BE Shaw, T Gooley, M Malkki, P Bardy, JD Bignon, ... The lancet oncology, 2012 | 414 | 2012 |
| Overview of monoclonal antibodies in cancer therapy: present and promise M Stern, R Herrmann Critical reviews in oncology/hematology 54 (1), 11-29, 2005 | 371 | 2005 |
| Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation JR Passweg, A Tichelli, S Meyer-Monard, D Heim, M Stern, T Kühne, ... Leukemia 18 (11), 1835-1838, 2004 | 327 | 2004 |
| Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease N Cantoni, HH Hirsch, N Khanna, S Gerull, A Buser, C Bucher, J Halter, ... Biology of blood and marrow transplantation 16 (9), 1309-1314, 2010 | 293 | 2010 |
| Survival after T cell–depleted haploidentical stem cell transplantation is improved using the mother as donor M Stern, L Ruggeri, A Mancusi, ME Bernardo, C de Angelis, C Bucher, ... Blood, The Journal of the American Society of Hematology 112 (7), 2990-2995, 2008 | 288 | 2008 |
| Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation A Tichelli, C Bucher, A Rovó, G Stussi, M Stern, M Paulussen, J Halter, ... Blood, The Journal of the American Society of Hematology 110 (9), 3463-3471, 2007 | 274 | 2007 |
| Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers M Stern, JR Passweg, S Meyer-Monard, R Esser, T Tonn, J Soerensen, ... Bone marrow transplantation 48 (3), 433-438, 2013 | 200 | 2013 |
| HY as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study A Gratwohl, B Döhler, M Stern, G Opelz The Lancet 372 (9632), 49-53, 2008 | 178 | 2008 |
| Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2× 11 arterial regions M Aschwanden, F Kesten, M Stern, C Thalhammer, UA Walker, A Tyndall, ... Annals of the rheumatic diseases 69 (7), 1356-1359, 2010 | 167 | 2010 |
| Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment M Stern, H Hirsch, A Cusini, C van Delden, O Manuel, P Meylan, ... Transplantation 98 (9), 1013-1018, 2014 | 160 | 2014 |
| Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol U Koehl, C Brehm, S Huenecke, SY Zimmermann, S Kloess, M Bremm, ... Frontiers in oncology 3, 118, 2013 | 160 | 2013 |
| Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1 M Stern, L Ruggeri, M Capanni, A Mancusi, A Velardi Blood, The Journal of the American Society of Hematology 112 (3), 708-710, 2008 | 145 | 2008 |
| The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients M Stern, H Elsässer, G Hönger, J Steiger, S Schaub, C Hess American Journal of Transplantation 8 (6), 1312-1317, 2008 | 142 | 2008 |
| Haploidentical hematopoietic transplantation from KIR ligand–mismatched donors with activating KIRs reduces nonrelapse mortality A Mancusi, L Ruggeri, E Urbani, A Pierini, MS Massei, A Carotti, A Terenzi, ... Blood, The Journal of the American Society of Hematology 125 (20), 3173-3182, 2015 | 139 | 2015 |
| Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis M Stern, LC De Wreede, R Brand, A Van Biezen, P Dreger, M Mohty, ... Leukemia 28 (11), 2235-2240, 2014 | 126 | 2014 |
| Use of natural killer cells in hematopoetic stem cell transplantation JR Passweg, M Stern, U Koehl, L Uharek, A Tichelli Bone marrow transplantation 35 (7), 637-643, 2005 | 119 | 2005 |
| Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia … U Siegler, S Meyer-Monard, S Jörger, M Stern, A Tichelli, A Gratwohl, ... Cytotherapy 12 (6), 750-763, 2010 | 115 | 2010 |
